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Background and objective: The epidemiology of the forty percent of tuberculosis patients
who present with disseminated and/or extrapulmonary disease is in need of further study.
Further study of such dissemination using published data from international indices may
provide data which assist with control of tuberculosis.
Methods: For each clinical or epidemiologic factor studied, summary odds ratios and corre-
sponding 95% confidence intervals were calculated showing associations between such
factors and documented extrapulmonary dissemination of tuberculosis.
Results: Eighteen studies fulfilled criteria for study of the clinical factors and nine for the
cytokine studies. Significant factors associated with a greater risk of extrapulmonary dis-
semination were female gender (summary odds ratio, 1.92 (95% confidence intervals,
1.72–2.13), I-squared 86.9), age under 45 (1.37, 1.18–1.60, 63.7), and as well the absence of
smoking, drinking and diabetes but not HIV infection (1.10, 0.91–1.32, 80.5). Among cyto-
kines, the macrophage receptor protein P2X7 was associated most strongly associated with
extrapulmonary dissemination of tuberculosis (2.28, 0.88–5.90, 92.9).
Conclusion: Young age, female gender, and the macrophage purinergic receptor protein
P2X7 were major factors associated with extrapulmonary dissemination of tuberculosis.
Published by Elsevier Ltd. on behalf of Asian-African Society for Mycobacteriology.Introduction Is it possible to answer questions about risk factors forThe extrapulmonary dissemination of tuberculosis (TB) is the
result of pathogen, host genetic and environmental factors.
The relative importance of these factors is a debatable topic.
The known pathogen factors include the particular virulence
of certain types, such as the Beijing strain, which is associated
with extrapulmonary disease [1], as well as biologic properties
of disseminating pathogens as shown bymice studies in which
variants of a heparin-binding hemagglutinin are associated
with an increased risk of disseminated disease [2].extrapulmonary disease simply by referring to published data
from international indices? Data provided by the World
Health Organization (WHO) and the Centers for Disease Con-
trol and Prevention (CDC) provide widely disparate values for
the incidence of extrapulmonary tuberculosis [3–5]. For exam-
ple, Cambodia reports that 37% of their reported (TB) cases are
extrapulmonary, while China reports only 7% [4]. The overall
rate is 11.6% for high-risk nations and 13.1% for all nations
in this WHO report, while a CDC report for the same period
lists a rate of 19% for extrapulmonary disease [3]. Age andf America.
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cited in the most recent WHO report [4]. The recognized fact
that up to 40% of extrapulmonary cases also contain pulmon-
ary disease complicates any analysis [6].
Host factors are also important in extrapulmonary dissem-
ination and traditionally suggested by the fact that the hu-
man immunodeficiency virus (HIV)-infected [7,8] and
patients with other immunosuppressive diseases such as sys-
temic lupus erythematosus [9] show an increased risk of
extrapulmonary dissemination when infected with Mycobac-
terium tuberculosis. The biologic basis for this host susceptibil-
ity is the subject of many studies, dating back to early NIH
studies when the then-classified HLA group Bw15 (‘‘w’’ for
‘‘working’’) was found in a small series to be associated with
extrapulmonary dissemination of TB [10].
To assess the correlates which are most strongly associ-
ated with extrapulmonary dissemination of TB, meta-analy-
ses of published series of TB were performed. This article
presents the findings of these meta-analyses.
Materials and methods
Searching for studies
PubMed database and Google Scholar were searched for stud-
ies comparing extrapulmonary tuberculosis (EPTB) to pul-
monary tuberculosis (PTB) controls. The search terms used
were: extrapulmonary OR extrathoracic AND pulmonary
AND tuberculosis within the title or abstract. Searches were
limited to the English language although all languages with
English translations were included. Abstracts and titles of
articles were scanned for key words (‘‘epidemiology,’’ ‘‘demo-
graphics,’’ ‘‘risk factors’’) indicating a comparative analysis.
The bibliographies of the first set of articles were reviewed
to locate additional articles.
Selecting studies and collecting articles and data
Studies were included if they: (a) compared data for EPTB and
PTB cases; (b) were published within the last 10 years
(because of the scarcity of earlier studies); and (c) provided
calculated odds ratios or sufficient data for the calculation
of such odds ratios. Studies were excluded if: (a) cases in
which clinically both EPTB and PTB were reported as part
of either group; (b) pleural TB cases were included in the
PTB group (because the convention is to include them as
EPTB); or (c) studies contained duplicate data from a larger
study. Due to large differences in available resources and
health care protocols between study sites, no studies were
excluded based on method of TB confirmation. When dupli-
cate papers using the same data were encountered, the
larger study was chosen. A sample search would include
the above variables, and examining the individual articles,
for example, for data on gender and then collating the rel-
evant articles.
Factors studies by meta-analysis
These meta-analyses were performed on analyzed factors
present in sufficient frequency for statistical analysis. Theseincluded gender, age, HIV status, African ancestry, smoking
and drinking history, the presence of diabetes, and the
presence of polymorphisms in five cytokines, including
interferon-gamma (c), tumor necrosis factor-alpha (a), inter-
leukin 10, toll-like receptor 2, and the macrophage protein
P2X7.
Limitations of factors used in meta-analysis
HIV-negativity was assumed when HIV status was reported
as unknown because without this restriction, few studies
were usable. Smoking, diabetes and excess alcohol drinking
habits were generally reported based on the authors’ assess-
ments, usually without specific definitions. Race was rarely
reported with detail. In the end, only African or non-African
ancestry reports were present in sufficient number or detail
to justify analysis. Age was reported with diverse stratifica-
tion and the most often used age for stratification (age 45,
4 studies) was used for this meta-analysis. The use of other
age cutoffs did not provide sufficiently large samples for
analysis.
Statistical analyses
Characteristics of patients reported in at least 2 eligible stud-
ies were analyzed using STATA software (version 11.0, College
Station, TX [11] and ‘‘metan’’ commands [12]). Meta-analysis
was performed using random effects analysis, and heteroge-
neity was measured using the I2 statistic. The studies were
analyzed with graphs produced with best fit lines showing
the odds ratio for extrapulmonary vs. pulmonary disease gi-
ven the presence of a studied demographic, trait, behavior,
or polymorphism. For cytokine and molecular polymor-
phisms, absolute allele numbers and associated proportions
were used rather than specific genotypes, and the search cri-
teria were limited by the paucity of polymorphism articles re-
lated to dissemination of TB.
Results
From 1257 articles generated in the initial search, 27 met
the inclusion criteria and 3 additional articles were found
using bibliographies in the 27; among the 30 articles, 11
were excluded for combining pulmonary and extrapulmo-
nary disease, 3 were excluded for equating pleural with
pulmonary disease, 1 was excluded for duplicate data, an
additional 3 were located in reviewing data, and the final
18 were suitable for inclusion in the meta-analysis. Large
public health databases (CDC, WHO) did not typically con-
tain sufficient detail regarding combined pulmonary and
extrapulmonary cases and thus did not fit the inclusion
criteria for the study.
The proportion of cases confirmed by culture varied by
study and this proportion was often not reported. The
remaining cases were confirmed by a variety of methods
including microscopy, histology, and clinical decision-
making.
The data analyzed on cytokines and immune polymor-
phisms were based on reviews of 30 recent publications,
and data from 9 articles met criteria for the study.
NOTE: Weights are from random effects analysis
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Gender and Age in Extrapulmonary Tuberculosis
Fig. 1 – The odds ratio of extrapulmonary to pulmonary disease (EP/P) with 95% confidence intervals for female gender and
age (divided at 45 years). Subtotal, I-squared = 86.9% and 63.7% respectively, P < 0.001 (gender), and P = 0.041 (age) for models,
random effects model.
Table 1 – Assessing odds ratios of dissemination (defined as EPTB/PTB >1) by epidemiologic and host factors.
Risk factor N Odds ratio I2 Value
Female gender 17 1.92 (1.72–2.13) 86.9
HIV positive 7 1.10 (0.91–1.32) 80.5
Black African ancestry 4 0.97 (0.95–0.99) 0.00
Age under 45 4 1.37 (1.18–1.60) 63.7
History of diabetes 3 0.52 (0.14–1.97) 94.8
History of smoking 2 0.28 (0.22–0.36) 11.6
History of heavy alcohol use 2 0.24 (0.15–0.39) 77.8
Interferon-c 874T/A 4 1.03 (0.53–2.01) 83.0
Toll-like receptor-2 Arg753Gln 2 0.71 (0.38–1.33) 0.00
Tumor necrosis factor-a 308G/A 3 1.21 (0.82–1.79) 0.00
Macrophage protein P2X7 1512A/C 3 2.28 (0.88–5.90) 92.9
Interleukin-10 1082G/A 4 0.88 (0.65–1.19) 38.2
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 3 ( 2 0 1 4 ) 9 –1 6 11The data show that the factors associated with a sta-
tistically higher proportion of extrapulmonary to pulmon-
ary desease are female gender or age under 45 while
the factors associated with a statistically lower proportion
of extrapulmonary to pulmonary disease are Africanancestrage and a history of smoking or alcohol usage
(Table 1).
The largest number of studies available for meta-analyses
were for gender (17), followed by HIV positivity (7), black
African ancestry (4), age cutoff at 45 (4), and interferon-c
NOTE: Weights are from random effects analysis
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HIV and Diabetes in Extrapulmonary Tuberculosis
Fig. 2 – The odds ratio of extrapulmonary to pulmonary disease (EP/P) with 95% confidence intervals for human
immunodeficiency virus (HIV) infection status and diabetes. Subtotal I-squared = 80.5% and 94.8%, respectively, P < 0.001 for
both for models, random effects model.
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smaller number of studies were available for meta-analyses
for a history of diabetes (3), a history of heavy drinking (2)
or a history of smoking (2), and with the polymorphisms in
P2X7 1512A/C (3), tumor necrosis factor-a 308G/A (3), and
toll-like receptor -2 Arg753Gln (2).
Both female gender andyouthwere significantly associated
with a higher ratio of extrapulmonary to pulmonary disease
(Table 1, Fig. 1) with HIV-positivity showing aweak association
(Table 1, Fig. 2). A history of diabetes, heavy alcohol usage
or smoking was all associated with a lower ratio of
extrapulmonary to pulmonary disease. Among the immuno-
logic factors assessed in this study, the P2X7 (-1513 A/C) and
TNF-a (-308G/A) polymorphisms showed ahigher ratio of EPTB
to PTB, whereas the TLR-2 (-753 Arg/Gln) and IL-10 (-1028 G/A)
polymorphisms showed trends toward lower EPTB to PTB
ratios. There was no detected association between the
interferon-gamma (IFN-c) polymorphism examined and the
EPTB/PTB ratio (Table 1, Fig. 3).
The random-effects model was applied with the presence
of significant heterogeneity among studies showing high I-
squared value for all but four factors: black African ancestry
history of smoking, and two of the cytokine/immunepolymorphisms (the TLR-2 and TNF-a reported polymor-
phisms) (Table 1).
Discussion
The extrapulmonary dissemination of TB is the subject of
multiple past reviews. These reviews include variables show-
ing a greater predilection by female gender, HIV infection,
race, age and personal history of diabetes, alcoholism and
smoking. The more recently recognized role of multiple bio-
logic pathogen factors is much harder to analyze, for while
at least 10 such factors are now identified (including interleu-
kin-1 receptor polymorphisms [13–16], IFN-c [13,16,17], inter-
leukin-6 [13,14,16], interleukin-12 [18], toll-like receptor 2
[15,17,19–21], CCL2 [22,23], and NRAMP [now called solute
carrier family 11A1 or SLC11A1] [24–26]), there are few studies
examining their role in the pathogenesis of the different
forms of TB.
Gender was identified in an assessable fashion in 17 stud-
ies [8,14,15,19,23,27–36]. As emphasized in the large CDC re-
view [33], men are at greater risk for both pulmonary and
extrapulmonary TB, but the male to female ratio is lower for
extrapulmonary disease. This is evident in Fig. 1 where the
NOTE: Weights are from random effects analysis
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Fig. 3 – The odds ratio of extrapulmonary to pulmonary disease (EP/P) with 95% confidence intervals for five selected cytokine
and immunologic polymorphisms. TLR, toll-like receptor; IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; P2X7,
purinoreceptor 7; I-square and P values given on chart, random effects model.
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higher in women.
HIV infection is the classic immunosuppressive state thought
to be associated with extrapulmonary dissemination although
the reports from Turkey of the association with systemic lupus
erythematosus [9] predate this. In compiling the seven studies
in a meta-analysis [8,28,29,32,33,35,37], the combined odds ratio
suggests that the extrapulmonary dissemination occurs at only
a slightly increased level with HIV infection.
The diversity of races makes race a difficult factor to study.
Because a group of articles report African ancestry in compar-
ison with other races, the racial analysis was limited to the
four studies [15,32,33,35], which include mention of black
African vs. other ancestry. The large CDC study [33] is allotted
nearly the entire weight in this meta-analysis (99%) and
therefore it is not surprising that the meta-analysis odds ratio
corresponds closely with that of the large CDC study. Thus,
while African ancestry is known to predispose to TB, thereis only a minimal black racial predilection towards EPTB
based on this analysis.
Age is another factor difficult to study because of the
inconsistency of age grouping or cutoffs. The use of age 45
in a dichotomous fashion does not allow for assessing a gra-
dation with age. The four articles with this age [8,32,35,36]
cutoff showed as expected a lower odds ratio for extrapulmo-
nary/pulmonary disease among patients older than 45.
A new set of articles shows the importance of diabetes
mellitus in predilection toward TB, but only three were
included in the meta-analysis [29,31,37] due to exclusion
criteria. The results suggest a lower predilection for extrapul-
monary disease in diabetics although the severity of diabetes
could not be assessed and the anticipated confounding effect
of age complicates any analysis.
With respect to the habits of drinking or smoking, the
small number of studies included in the meta-analysis
showed higher rates of extrapulmonary disease in those not
14 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 3 ( 2 0 1 4 ) 9 –1 6engaged in these habits. Again, such factors would in a large,
future study need analysis of co-factors, including especially
age and gender.
The impacts of various immunologic factors on the clinical
form of TB are studied in but a few papers to date.
The strongest association was with the purinoceptor 7
(P2X7) receptor polymorphism. This protein receptor is a
selective cation channel found in high concentration on mac-
rophages. Its activation induces apoptosis and activates phos-
pholipase D, which promotes mycobacterial killing in
macrophages [38]. The inability of such macrophages to
appropriately kill mycobacteria might predispose one to dis-
seminated disease.
The role of TNF-a in controlling TB in humans is recognized
from the high incidence of TB in rheumatoid arthritis patients
taking anti-TNF-a monoclonal antibodies [14]. TNF-a is also
implicated in host-mediated lung damage [14,39]. The -308
G/A polymorphism upregulates TNF-a production and is
known to be associated with severe forms of other infectious
diseases [14,40]. There are mixed data on whether this poly-
morphism increases susceptibility to TB [14,39,40], but higher
serum concentrations of TNF-a are seen in association with
severe vs. mild TB [40]. High levels of TNF-a may damage host
tissues and impair containment of mycobacteria.
The TLR-2 (-753 Arg/Gln) polymorphism showed the low-
est ratio of EPTB to PTB (yet not statistically significant)
among biologic factors studied. TLR-2 activates macrophages
in response to mycobacteria [19,41] and leads to further cyto-
kine production, including TNF-a [19]. Several TLR-2 polymor-
phisms are implicated in TB disease, and it is reported that a
number of these polymorphisms may be associated with
extrapulmonary disease [21]. The TLR-2 polymorphism exam-
ined herein leads to decreased macrophage response and is
found more often in patients diagnosed with TB [41]. This
same polymorphism is implicated in susceptibility to other
infectious diseases, including group A hemolytic Streptococ-
cal infections [19]. The impaired recognition of mycobacteria
with this TLR-2 polymorphism is consistent with the data re-
ported herein showing a lower EPTB/PTB ratio.
The anti-inflammatory cytokine IL-10 down-regulates the
Th1 immune response and lowers levels of IFN-c. Previous
studies show varied associations between IL-10 polymor-
phisms and susceptibility to TB [14,39,42]. IL-10 can
‘‘deactivate’’ macrophages and reduce mycobacteria-induced
apoptosis of macrophages. IL-10 deficient mice show im-
proved immunity to mycobacteria [14]. This studied polymor-
phism is associated with a low IL-10 state [14,42] which can
lead to an increase in macrophage activity. This improved im-
mune responsemay help to contain the infection at the initial
infection site in the lungs and prevent dissemination, leading
to a lower EPTB/PTB ratio as seen in these data. (Table 1).
IFN-c is an important cytokine down-regulated by IL-10,
also involved in the activation of macrophages and subse-
quent destruction of mycobacteria [14,27,42,43]. The -874
T/A polymorphism studied herein reduces IFN-c levels, a
state associated with a higher frequency of TB when com-
pared with healthy controls [27,42,43]. The low IFN-producing
allele is reportedly seen more often both in EPTB [43] and PTB
[14]. Differences in populations and therefore a myriad of
other co-factors likely account for this discrepancy and thesedata do not suggest a significant association between IFN-c
and the ratio of EPTB/PTB.
Is there a specificity of organ system involvement based on
immunologic factors? In former reports, systemic cases of TB
showed a predilection for HLA type DQB1*03 [44]. The tendency
of TB to manifest itself in non-respiratory tissue dates to his-
torical discussions, particularly those of Johns Hopkins pathol-
ogist Arnold Rich, who described central nervous system TB as
the breakdown of a granulomatous focus (later called a ‘‘Rich
focus’’) [45]. Today, the many manifestations of TB suggest that
a variety of pathogenic mechanisms can be associated with
extrapulmonary dissemination, especially among the immu-
nosuppressed. It is not unreasonable that tissue specificity
may be impacted by HLA status, but most extrapulmonary dis-
ease is not associated with unique HLA loci.
The summary odds ratio table (Table 1) provided shows
that demographic, epidemiologic, and clinical factors are to
date strong factors in increasing the risk for extrapulmonary
dissemination of TB. Whether or not select polymorphisms of
cytokines and immunologic factors will be more important in
the future remains speculative. Because most of these latter
studies were only carried out in the last three to four years
and at a limited number of institutions, it will be important
to reassess their relative importance in determining the risk
of the dissemination of TB in the future.
Some of the data assessed in the meta-analysis are limited
by the number of studies available for inclusion. In many
excluded studies, the data were reported in sufficient detail,
but the definition of what constitutes an extrapulmonary case
would not allow inclusion. Other useful data were excluded
because pulmonary and extrapulmonary diseases were
counted only as part of the EPTB group or the two were re-
ported together. Such differences in definitions between and
within countries suggest the need for more uniform and
international standardized definitions in TB epidemiology.
Several I2 values calculated to assess heterogeneity among
studies included in meta-analysis are above 75%, a substantial
amount of heterogeneity [12]. Given that included studies var-
ied considerably in terms of design, purpose, size and geogra-
phy, the authors feel this level of heterogeneity was
inevitable. The ideal meta-analysis contains large numbers of
non-heterogeneous studies, and these data point to the need
for improved data collection and the surveillance of existing
scientific data, especially in the emerging field of cytokines.
Other factors that need assessment are the considerable
geographic variability for extrapulmonary disease, a variabil-
ity that may be a function of different assays, of immunoge-
netic factors, of socioeconomic factors, or of selective
reporting characteristics (why do rates of reported extrapul-
monary disease range from 7% in China to 22.3% in Afghani-
stan, and 37% in Cambodia?) [4]. Immigrants in several
studies show higher rates of extrapulmonary disease than
do native populations, and the proportion of immigrants
may also explain geographic foci of higher prevalence of
extrapulmonary disease [30,46,47]. The role of TB resistance
is also important and shows that many factors other than
the ones listed here may be important in determining the risk
for extrapulmonary dissemination [33,48].
In summary, the results here suggest that the prototype for
extrapulmonary TB is a young woman who is HIV-infected,
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 3 ( 2 0 1 4 ) 9 –1 6 15but does not have diabetes mellitus and who does not smoke
or drink excess alcohol, while the prototype for TB that does
not disseminate is an elderly male who smokes and drinks
excess alcohol, but who is not HIV-infected. The former pa-
tient is more likely to show lower levels of functional, active
protein P2X7 receptor. Future studies of the extrapulmonary
dissemination of TB should in particular concentrate on this
molecular factor. The presence and use of such clinical and
molecular factors may in the future be prognostic in deter-
mining which patients are likely to show or to develop dis-
seminated disease.
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